PCM
IMGN

Penserra Capital Management’s Immunogen Inc IMGN Stock Holding History

Penserra Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,630
Closed -$26K – 1602
2021
Q3 		$26K Buy
4,630
+80
+2% +$462 ﹤0.01% 1212
2021
Q2 		$29K Buy
4,550
+135
+3% +$942 ﹤0.01% 1101
2021
Q1 		$35K Buy
4,415
+45
+1% +$367 ﹤0.01% 879
2020
Q4 		$28K Buy
4,370
+2,880
+193% +$16.8K ﹤0.01% 803
2020
Q3 		$5K Buy
+1,490
New +$6.02K ﹤0.01% 862

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Penserra Capital Management's IMGN Position: Q4 2021 in Review

Penserra Capital Management sold out of Immunogen Inc (IMGN) in Q4 2021, closing a stake of 4,630 shares — an estimated $26K sold.

Penserra Capital Management first reported a position in IMGN in Q3 2020 and held it in 5 quarters. The position peaked at $35K in Q1 2021. 236 funds tracked by Wall St. Rank hold IMGN as of Q4 2021.

  • Penserra Capital Management reported no remaining Immunogen Inc position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 4,630 Immunogen Inc shares in Q4 2021, an estimated $26K.
  • Penserra Capital Management first reported a position in Immunogen Inc in Q3 2020 and held it in 5 quarters.
  • Penserra Capital Management's Immunogen Inc position peaked at $35K in Q1 2021.
  • 236 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.